SCHEMBL18924240

SCHEMBL18924240

Cc1cc(=O)c(C)c2oc3cc(O)ccc3nc1-2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.47
ESR2 Q92731 9/20 0.47
APP P05067 3/20 0.45
HSD17B3 P37058 5/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 2/20 0.40
CYP2C9 P11712 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CA12 O43570 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
AKR1B1 P15121 1/20 0.40
HPGD P15428 1/20 0.40
UGT1A1 P22309 1/20 0.40
MAOB P27338 1/20 0.40
CASP1 P29466 1/20 0.40
KDR P35968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16069663 0.86 KDM4E (0.46) NPC1RAB9AALDH1A1CYP2C9KDM4E
SCHEMBL18924201 0.82 ALDH1A1 (0.47) ESR1ESR2APPHSD17B3NPC1
SCHEMBL16069697 0.81 MAPT (0.49) NPC1RAB9AALDH1A1CYP2C9KDM4E
SCHEMBL16069657 0.81 PDE3B (0.41) APPNPC1RAB9A
SCHEMBL16069659 0.80 ALDH1A1 (0.40) NPC1RAB9AALDH1A1CYP2C9KDM4E
SCHEMBL13212103 0.80 APP (0.57) ESR1ESR2APPHSD17B3NPC1
SCHEMBL16069665 0.77 RAB9A (0.49) NPC1RAB9AALDH1A1KDM4ELMNA
SCHEMBL18924241 0.76 CA12 (0.50) APPNPC1RAB9AALDH1A1KDM4E
SCHEMBL18924100 0.76 MAOB (0.52) APPNPC1RAB9ACA12MAOB
SCHEMBL29814693 0.76 APP (0.59) ESR1ESR2APPHSD17B3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670170-B2 Resorufin derivatives for treatment of oxidative stress disorders BIOELECTRON TECHNOLOGY CORPORATION (US) 2017-06-06 US disclosed